Category: New products
-
AI System Shown to Provide Early Sepsis Warnings
A system using machine learning algorithms is shown to provide early warnings about sepsis developing in hospitalized patients, reducing injury and death.
-
Trial Okayed for Engineered Cell Cancer Therapy
A clinical trial is set to begin testing engineered immune-system cells designed to precisely target and infiltrate cancerous tumors without other potentially toxic proteins.
-
Trial Shows Oral Covid-19 Vaccine Produces Antibodies
A clinical trial shows a Covid-19 vaccine taken as a tablet produces protective antibodies in nasal membranes that in some cases last for up to a year.
-
Surgical Robotics Company Raises $55M in Early Funds
A developer of robotic systems for cataract and other eye surgeries is raising $55 million in its first venture financing round.
-
NIH Funding Engineered Phage Screening Device
National Institutes of Health is funding initial development of a microfluidic device that tests engineered viruses for their ability to kill disease-causing bacteria.
-
Precision Protein Design Start-Up Gains $40M in Early Funds
A start-up company designing and testing precise proteins within live animals to speed creation of new therapeutics is raising $40 million in its first venture round.
-
Biotechs Explore Gut-Brain Axis for Mental Health
Two biotechnology companies are advancing basic research findings connecting gut microbes with the brain to develop new therapies for neurological disorders.
-
Trial Begins of Precise Gene Editing for Heart Disease
A clinical trial is underway evaluating a precise form of Crispr gene editing as a one-time therapy for an inherited form of heart disease.
-
Diabetes Cell Therapy Biotech Acquired in $320M Deal
A developer of therapies derived from stem cells to replace malfunctioning islet cells in people with type 1 diabetes was acquired by Vertex Pharmaceuticals.
-
AI Analytics Find New ALS Genetic Drug Targets
Researchers analyzed medical and scientific databases with algorithms to identify eight previously unreported biomarkers contributing to neurodegeneration similar to ALS.